Find paid clinical trials. Understand the time, pay, and process.
"Found a sleep study in 3 days. The compensation estimate was spot on!"
"Finally a way to search trials that doesn't feel like 1995. Super clean."
"The first-timer guide helped me understand what to expect. Great resource."
| Category | Location | |||||
|---|---|---|---|---|---|---|
| Est. $1,950 – $18,000 | GlaxoSmithKline | Vaccines | Phase 1 / Phase 2 | Lenexa, Kansas | 448 | |
| Est. $1,950 – $18,000 | Pfizer | Vaccines | Phase 1 | Lake Forest, California | 372 | |
| Est. $1,950 – $18,000 | Pfizer | Vaccines | Phase 1 | Anaheim, California | 310 | |
| Est. $1,950 – $18,000 | Vertex Pharmaceuticals Incorporated | Pharma | Phase 1 | Hollywood, Florida | 255 | |
| Est. $1,950 – $18,000 | Novartis Pharmaceuticals | Pharma | Phase 1 / Phase 2 | Stanford, California | 232 | |
| Est. $1,950 – $18,000 | AstraZeneca | Pharma | Phase 1 / Phase 2 | Huntsville, Alabama | 231 | |
| Est. $1,950 – $18,000 | Merck Sharp & Dohme LLC | Vaccines | Phase 1 | Topeka, Kansas | 210 | |
| Est. $1,950 – $18,000 | Eli Lilly and Company | Weight Loss | Phase 1 | Daytona Beach, Florida | 201 | |
| Est. $1,950 – $18,000 | Merck Sharp & Dohme LLC | Vaccines | Phase 1 | Glendale, California | 200 | |
| Est. $1,950 – $18,000 | Pfizer | Vaccines | Phase 1 | Nanning, Guangxi | 200 | |
| Est. $1,950 – $18,000 | Eli Lilly and Company | Pharma | Phase 1 | Anaheim, California | 196 | |
| Est. $1,950 – $18,000 | Bristol-Myers Squibb | Diet & Nutrition | Phase 1 / Phase 2 | Birmingham, Alabama | 184 | |
| Est. $1,950 – $18,000 | AstraZeneca | Pharma | Phase 1 | Glendale, California | 176 | |
| Est. $1,950 – $18,000 | Novartis Pharmaceuticals | Pharma | Phase 1 / Phase 2 | Miami, Florida | 161 | |
| Est. $1,950 – $18,000 | Regeneron Pharmaceuticals | Pharma | Phase 1 | Glendale, California | 156 | |
| Est. $1,950 – $18,000 | Vertex Pharmaceuticals Incorporated | Pharma | Phase 1 | Overland Park, Kansas | 148 | |
| Est. $1,950 – $18,000 | Eli Lilly and Company | Weight Loss | Phase 1 | Los Alamitos, California | 144 | |
| Est. $1,950 – $18,000 | Eli Lilly and Company | Diet & Nutrition | Phase 1 | Anaheim, California | 144 | |
| Est. $1,950 – $18,000 | GlaxoSmithKline | Diet & Nutrition | Phase 1 | Cambridge | 144 | |
| Est. $1,950 – $18,000 | GlaxoSmithKline | Vaccines | Phase 1 | Scottsdale, Arizona | 142 | |
| Est. $1,950 – $18,000 | AstraZeneca | Vaccines | Phase 1 | Glendale, California | 136 | |
| Est. $1,950 – $18,000 | Eli Lilly and Company | Pharma | Phase 1 | Anniston, Alabama | 134 | |
| Est. $1,950 – $18,000 | Eli Lilly and Company | Pharma | Phase 1 | Neuss | 132 | |
| Est. $1,950 – $18,000 | GlaxoSmithKline | Vaccines | Phase 1 | Yuma, Arizona | 130 | |
| Est. $1,950 – $18,000 | Hoffmann-La Roche | Pharma | Phase 1 | Christchurch | 128 | |
| Est. $1,950 – $18,000 | Vertex Pharmaceuticals Incorporated | Pharma | Phase 1 | Overland Park, Kansas | 128 | |
| Est. $1,950 – $18,000 | Eli Lilly and Company | Pharma | Phase 1 | Los Alamitos, California | 127 | |
| Est. $1,950 – $18,000 | Merck Sharp & Dohme LLC | Vaccines | Phase 1 | Hallandale, Florida | 126 | |
| Est. $1,950 – $18,000 | Amgen | Pharma | Phase 1 | Lake Forest, California | 124 | |
| Est. $1,950 – $18,000 | AstraZeneca | Pharma | Phase 1 | Glendale, California | 124 | |
| Est. $1,950 – $18,000 | Pfizer | Pharma | Phase 1 | Anaheim, California | 119 | |
| Est. $1,950 – $18,000 | Eli Lilly and Company | Pharma | Phase 1 | Neuss | 118 | |
| Est. $1,950 – $18,000 | Novartis Pharmaceuticals | Pharma | Phase 1 | Miami, Florida | 112 | |
| Est. $1,950 – $18,000 | GlaxoSmithKline | Vaccines | Phase 1 | Botany, New South Wales | 108 | |
| Est. $1,950 – $18,000 | Bristol-Myers Squibb | Pharma | Phase 1 | Anaheim, California | 106 | |
| Est. $1,950 – $18,000 | Eli Lilly and Company | Pharma | Phase 1 | Holbeck, Leeds | 104 | |
| Est. $1,950 – $18,000 | Biogen | Pharma | Phase 1 | Austin, Texas | 104 | |
| Est. $1,950 – $18,000 | Eli Lilly and Company | Pharma | Phase 1 | Los Alamitos, California | 104 | |
| Est. $1,950 – $18,000 | AbbVie | Vaccines | Phase 1 | Anaheim, California | 100 | |
| Est. $1,950 – $18,000 | AbbVie | Pharma | Phase 1 | Grayslake, Illinois | 96 | |
| Est. $1,950 – $18,000 | Pfizer | Pharma | Phase 1 | Brussels, Bruxelles-capitale, Région de | 92 | |
| Est. $1,950 – $18,000 | Amgen | Diet & Nutrition | Phase 1 | Lake Forest, California | 92 | |
| Est. $1,950 – $18,000 | Eli Lilly and Company | Pharma | Phase 1 | Los Alamitos, California | 88 | |
| Est. $1,950 – $18,000 | Regeneron Pharmaceuticals | Pharma | Phase 1 | Christchurch, Canterbury | 88 | |
| Est. $1,950 – $18,000 | Amgen | Pharma | Phase 1 / Phase 2 | Little Rock, Arkansas | 88 | |
| Est. $1,950 – $18,000 | AbbVie | Vaccines | Phase 1 | Anaheim, California | 87 | |
| Est. $1,950 – $18,000 | Eli Lilly and Company | Weight Loss | Phase 1 | Madison, Wisconsin | 84 | |
| Est. $1,950 – $18,000 | GlaxoSmithKline | Pharma | Phase 1 | Brussels | 84 | |
| Est. $1,950 – $18,000 | Amgen | Weight Loss | Phase 1 | Anaheim, California | 80 | |
| Est. $1,950 – $18,000 | Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) | Pharma | Phase 1 | Mount Royal | 80 |
Data from ClinicalTrials.gov (NIH/NLM). Pay estimates are approximate and not confirmed by sponsors. We do not provide medical advice. Always contact the study team directly to confirm compensation, eligibility, and risks.
Psilocybin, MDMA, ketamine, and cannabis studies recruiting healthy volunteers. Psychedelic research is expanding rapidly with university and pharma sponsors.
Flu, COVID, RSV, and experimental vaccine trials. Vaccine studies are among the most common opportunities for healthy adult volunteers.
GLP-1, semaglutide, and next-generation obesity drug studies. The weight loss drug market is booming and trials need healthy volunteers for Phase 1 testing.
Probiotics, supplements, microbiome, and dietary intervention studies. Often shorter commitments with simpler protocols than drug studies.
fMRI, EEG, cognitive testing, sleep, and neurostimulation research. Neuroscience labs need healthy brains for comparison studies and imaging.
Phase 1 first-in-human trials from Pfizer, Eli Lilly, Novartis, and more. These pay the most and are the backbone of healthy volunteer research.